Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) was upgraded by Barclays to a “strong sell” rating in a research note issued to investors on Tuesday, Zacks.com reports.
Separately, Royal Bank of Canada upgraded Recordati Industria Chimica e Farmaceutica to a “hold” rating in a research report on Monday, October 7th.
View Our Latest Stock Analysis on RCDTF
Recordati Industria Chimica e Farmaceutica Price Performance
Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $0.70 EPS for the quarter. Recordati Industria Chimica e Farmaceutica had a return on equity of 30.78% and a net margin of 17.41%. The business had revenue of $622.00 million for the quarter.
About Recordati Industria Chimica e Farmaceutica
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
See Also
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- With Risk Tolerance, One Size Does Not Fit All
- WD-40 Company Gears Up for a Double-Digit Stock Advance
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Monster and Celsius Energized: Which Stock Offers More Upside?
- Health Care Stocks Explained: Why You Might Want to Invest
- Sherwin-Williams Plunges Into Buying Opportunity: Time to Buy?
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.